<DOC>
	<DOCNO>NCT02670239</DOCNO>
	<brief_summary>Ex vivo lung perfusion ( EVLP ) establish strategy evaluate optimize high-risk donor lung would otherwise reject transplantation mainly due presence edema infection . Extracorporeal circuit may negatively affect pharmacokinetic ( PK ) several drug include antibiotic , thus expose patient risk therapeutic failure drug toxicity . The investigator set examine concentration imipenem lung perfusate lung biopsy EVLP , clinical impact .</brief_summary>
	<brief_title>Pharmacokinetics Imipenem During Ex Vivo Lung Perfusion ( EVLP )</brief_title>
	<detailed_description />
	<criteria>1 . Best PaO2/FiO2 &lt; 300 mmHg ; 2 . Pulmonary edema chest XRay ; 3 . Poor inflation deflation visual inspection ; 4 . Need blood transfusion 10U ; 5 . Maastricht category III/IV 1 . Diagnosis pneumonia ; 2. severe mechanical injury ; 3. gross gastric aspiration</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>